ストックスクリーナーアプリを入手
0.1173
45.92%
-0.0996
アフターアワーズ：
.11
-0.0073
-6.22%
前日終値:
$0.2169
開ける：
$0.12715
24時間の取引高:
37.84M
Relative Volume:
2.83
時価総額：
$16.93M
収益：
-
当期純損益:
$-119.76M
株価収益率:
-0.0869
EPS:
-1.35
ネットキャッシュフロー:
$-55.17M
1週間 パフォーマンス:
-45.84%
1か月 パフォーマンス:
-87.11%
6か月 パフォーマンス:
-67.86%
1年 パフォーマンス:
-89.71%
1日の値動き範囲:
$0.11
$0.1293
1週間の範囲:
$0.11
$0.258
52週間の値動き範囲:
$0.11
$1.50
Applied Therapeutics Inc Stock (APLT) Company Profile
名前
Applied Therapeutics Inc
セクター
電話
212-220-9226
住所
545 FIFTH AVENUE, SUITE 1400, NEW YORK, NY
APLT を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
APLT
Applied Therapeutics Inc
|
0.1173 | 31.30M | 0 | -119.76M | -55.17M | -1.35 |
|
VRTX
Vertex Pharmaceuticals Inc
|
452.04 | 113.14B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
741.29 | 78.49B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
877.94 | 54.76B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
397.55 | 54.51B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
197.01 | 41.64B | 447.02M | -1.18B | -906.14M | -6.1812 |
Applied Therapeutics Inc Stock (APLT) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-12-12 | ダウングレード | Robert W. Baird | Outperform → Neutral |
| 2025-12-03 | ダウングレード | Leerink Partners | Outperform → Market Perform |
| 2024-12-23 | ダウングレード | William Blair | Outperform → Mkt Perform |
| 2024-12-02 | ダウングレード | UBS | Buy → Neutral |
| 2024-11-29 | ダウングレード | RBC Capital Mkts | Outperform → Sector Perform |
| 2024-07-31 | 開始されました | William Blair | Outperform |
| 2024-03-26 | 開始されました | RBC Capital Mkts | Outperform |
| 2024-02-22 | 開始されました | Leerink Partners | Outperform |
| 2022-01-04 | ダウングレード | Barclays | Overweight → Equal Weight |
| 2021-08-27 | ダウングレード | Goldman | Neutral → Sell |
| 2021-06-25 | 再開されました | Goldman | Neutral |
| 2020-10-08 | 開始されました | Truist | Buy |
| 2020-04-22 | 開始されました | Goldman | Buy |
| 2020-02-27 | 開始されました | Barclays | Overweight |
| 2019-06-10 | 開始されました | Citigroup | Buy |
| 2019-06-10 | 開始されました | Cowen | Outperform |
| 2019-06-10 | 開始されました | Robert W. Baird | Outperform |
すべてを表示
Applied Therapeutics Inc (APLT) 最新ニュース
Halper Sadeh LLC Encourages ALEX, DXLG, APLT Shareholders to Contact the Firm to Discuss Their Rights - GlobeNewswire Inc.
Applied Therapeutics stock rating downgraded to Neutral by Baird - Investing.com Nigeria
Cycle buying Applied Therapeutics to develop CNS drugs - BioWorld MedTech
S&P 500 Down 1%; Broadcom Earnings Top Views - Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga
Cycle Pharma to acquire Applied Therapeutics - The Pharma Letter
Cycle Group Holdings Limited entered into a definitive agreement to acquire Applied Therapeutics, Inc. for $13.4 million. - marketscreener.com
Dow Rises Over 100 Points; Lululemon Posts Upbeat Q3 Earnings - Benzinga
Applied Therapeutics (APLT) Stock News Today: Cycle Deal Details, CVR Upside, and Analyst Outlook (Dec. 12, 2025) - ts2.tech
RBC Cuts Price Target on Applied Therapeutics to $0.25 From $1, Keeps Sector Perform, Speculative Risk - marketscreener.com
APLT Stock Alert: Halper Sadeh LLC is Investigating Whether the Sale of Applied Therapeutics, Inc. is Fair to Shareholders - The AI Journal
Applied Therapeutics Announces Merger with Cycle Group - TipRanks
Applied Therapeutics plunges after UK's Cycle Group to buy co - TradingView — Track All Markets
Why Lululemon Shares Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket - Benzinga
Applied Therapeutics stock price target lowered by RBC on Cycle acquisition - Investing.com UK
Applied Therapeutics To Be Acquired By Privately Held Cycle Group - Nasdaq
Cycle Pharmaceuticals acquiring Applied Therapeutics - MSN
Cycle Group to Acquire Applied Therapeutics (APLT) in Strategic Deal - GuruFocus
Cycle Pharmaceuticals to Acquire Applied Therapeutics - The Manila Times
Published on: 2025-12-05 04:31:49 - Newser
Is Applied Therapeutics Inc. stock a buy on dipsJuly 2025 Gainers & Weekly Sector Rotation Insights - Newser
Is Applied Therapeutics Inc. (2UV) stock prepared for digital transition2025 Short Interest & Verified Technical Signals - Newser
Can Applied Therapeutics Inc. (2UV) stock surprise markets with earningsPortfolio Growth Summary & High Accuracy Buy Signal Tips - Newser
How Applied Therapeutics Inc. (2UV) stock moves in volatile trading sessions2025 Trade Ideas & Real-Time Stock Movement Alerts - Newser
Can Applied Therapeutics Inc. (2UV) stock double in coming yearsWeekly Profit Recap & AI Optimized Trade Strategies - Newser
Applied Therapeutics stock rating downgraded by Leerink Partners on cash concerns - Investing.com Nigeria
APLT Downgraded by Leerink Partners: Key Analyst Update | APLT S - GuruFocus
Why Applied Therapeutics Inc. (2UV) stock fits value portfoliosTrade Performance Summary & Low Volatility Stock Suggestions - Newser
Why Applied Therapeutics Inc. (2UV) stock trades below fair value2025 Biggest Moves & Fast Moving Market Watchlists - Newser
What analysts say about Applied Therapeutics Inc stockHead and Shoulders Patterns & Minimal Investment Trading - earlytimes.in
Would You Still Hold Applied Therapeutics Stock If It Fell Another 30%? - Trefis
Applied Therapeutics (APLT) Upgraded to Buy: Here's Why - MSN
Applied Therapeutics Reports Third Quarter 2025 Financial Results - ADVFN
Finance Watch: Poxel Pulls Back From The Brink With Recovery Plan - Citeline News & Insights
Applied Therapeutics To Lay Off Nearly Half Its Staff, Board Explores M&A Options - MSN
Applied Therapeutics (APLT) Stock Price, Quote, News & History - Benzinga
Applied Therapeutics Investors Get 1st OK For $15M Deal - Law360
Why Applied Therapeutics Inc. stock could see breakout soonMarket Trend Review & Weekly Momentum Stock Picks - newser.com
Applied Therapeutics explores strategic alternatives amid workforce cuts By Investing.com - Investing.com Nigeria
Applied Therapeutics Announces Corporate Updates - Investing News Network
Applied Therapeutics, Inc. Initiates Strategic Alternatives Review - TradingView
Applied Therapeutics explores strategic alternatives amid workforce cuts - Investing.com
APLT Evaluates Strategic Options as Workforce Reductions Announced - GuruFocus
APLT Evaluates FDA Meeting Outcomes for Govorestat Development P - GuruFocus
What data driven models say about Applied Therapeutics Inc.’s future - newser.com
Applied Therapeutics (Nasdaq: APLT) to Explore Strategic Alternatives, Reduce Workforce 46% - Stock Titan
How Applied Therapeutics Inc. stock reacts to inflationary pressuresWeekly Trade Analysis & High Accuracy Swing Entry Alerts - newser.com
Applied Therapeutics Inc (APLT) 財務データ
収益
当期純利益
現金流量
EPS
Applied Therapeutics Inc (APLT) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Funtleyder Leslie D. | See Remarks |
Mar 04 '25 |
Sale |
0.44 |
14,502 |
6,381 |
390,459 |
| Chinoporos Constantine | See Remarks |
Mar 04 '25 |
Sale |
0.44 |
447 |
197 |
271,436 |
| Funtleyder Leslie D. | See Remarks |
Feb 06 '25 |
Sale |
0.61 |
22,950 |
14,000 |
404,961 |
| Perfetti Riccardo | Chief Medical Officer |
Feb 06 '25 |
Sale |
0.61 |
86,078 |
52,508 |
900,775 |
| Chinoporos Constantine | See Remarks |
Feb 06 '25 |
Sale |
0.61 |
28,117 |
17,151 |
271,883 |
1.08%
0.91%
大文字化:
|
ボリューム (24 時間):